Articles Matching "Pharmacy"

George Hartpence

George Hartpence, pharmacist and director on the Provista Pharmacy Operations team, offers more than 25 years of pharmacy expertise.

READ MORE 

Is CBD the Next Opportunity for Health Care?

Cannabidiol, also known as CBD, is becoming increasingly popular for consumers who want to use it for pain therapy and other medical applications. While interest in CBD and its uses continue to grow, non-acute healthcare providers need more information about its risks and benefits before recommending it to patients as a mainstream treatment.

READ MORE 

Where’s CMS Healthcare Money Going?

The Centers for Medicare & Medicaid Services (CMS) Office of the Actuary released its 2018-2027 Projections of National Health Expenditures. Not surprisingly, spending is expected to go up. See how much medical products and services will increase.

READ MORE 

8 Types of USP Approved PPE to Wear When Drug Compounding

Anyone involved in hazardous drug compounding, or shipping or handling hazardous drugs, must wear the proper personal protective equipment (PPE) to guard against exposure to the drugs, drug residue or hazardous drug waste materials. See our eight essential PPE products.

READ MORE 

Forecast Predicts 4.92% Increase in Pharmaceutical Prices for 2019

The annual Drug Price Forecast from Vizient®, Provista’s contracting partner, points to an increase in spend for pharmaceuticals between Jan. 1 and Dec. 31, 2019. The forecast predicts pricing for next year and explains the critical issues poised to affect the cost and use of pharmaceuticals.

READ MORE 

Making Good on the Promise of Biosimilars

Biosimilars are a newer class of drug that hold the potential to alter the healthcare landscape by offering lower prices than originator branded biologics. A biosimilar medicine is a biological medicine that’s almost an identical copy to a licensed biological medicine already in use. It’s been shown to not have any clinically meaningful differences from the original biological medicine in terms of quality, safety and efficacy. So why aren’t more available?

READ MORE 

2018-2019 Seasonal Influenza Vaccine

This white paper reviews the background, efficacy, and safety of the 2018-2019 seasonal influenza vaccine formulations.

READ MORE 

The Opioid Crisis Balancing Act

The opioid crisis, now a public health emergency, is challenging non-acute providers to improve opioid stewardship and prescribing practices. At the same time, they must manage the dispensation of opioid alternatives such as high-cost analgesics, whose comparative effectiveness isn’t well understood. This forces providers into a balancing act.

READ MORE 

Winning Strategies for Home Infusion Therapy Providers

The home infusion therapy market is growing rapidly and being influenced by new trends. At the same time, reimbursement and new therapies are creating challenges. To overcome obstacles, home infusion therapy providers must follow a proactive strategy that enables them to meet their profit margins while serving their patients’ needs.

READ MORE 

Infusion Solutions’ Rapid Growth Requires a Supply Chain Partner That Can Keep Up

Blake Gillum, the executive director for Infusion Solutions, has seen his company’s revenues and customer base double over the last five years. He needs a supply chain partner that can keep pace with his company’s rapid growth and new business offering of enteral feedings. In this case study, he explains how Provista offers the most aggressive contracts for the home infusion market, including Novaplus® private label injectables that deliver deep savings.

READ MORE 

Take the Next Steps to Powerful Purchasing.

Get Started